Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

SHSC:6990 Stock Report

Market Cap: HK$37.6b

Sichuan Kelun-Biotech Biopharmaceutical Future Growth

Future criteria checks 2/6

Sichuan Kelun-Biotech Biopharmaceutical is forecast to grow earnings and revenue by 30.8% and 25.2% per annum respectively. EPS is expected to grow by 32.2% per annum. Return on equity is forecast to be -28.5% in 3 years.

Key information

30.8%

Earnings growth rate

32.2%

EPS growth rate

Biotechs earnings growth35.2%
Revenue growth rate25.2%
Future return on equity-28.5%
Analyst coverage

Good

Last updated06 Jun 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:6990 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,520-59-2902029
12/31/20251,510-609-702-46611
12/31/20241,142-550-950-81910
12/31/20231,540-522-2360N/A
9/30/20231,523-427135207N/A
6/30/20231,505-333292355N/A
3/31/20231,155-440-942N/A
12/31/2022804-548-310-271N/A
12/31/202132-823-581-486N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6990 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 6990 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 6990 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 6990's revenue (25.2% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 6990's revenue (25.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6990 is forecast to be unprofitable in 3 years.


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.